They showed that: (1) FGF23 level was significantly elevated in HFpEF patients compared to controls; (2) FGF23 correlated with fibrosis estimated by extracellular volume measured by CMR T1 mapping; and (3) higher FGF23 concentration was associated with some proinflammatory co-morbidities, such as CKD, DM, and AF. Here, FGF23 is linked to chronic kidney disease.